Scott F Huntington

28PUBLICATIONS
91CO-AUTHORS
Nanotoxicology, health and safetyForensic epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 19, 2025
Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.

Megan Lee, Molly Schiffer, Iris Isufi

|Jul 28, 2025
Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Nikolai A Podoltsev

|Dec 20, 2024
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia.

Scott F Huntington, Joanna M Rhodes, Beenish S Manzoor

|Aug 08, 2024
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas.

Mengyang Di, Kunal C Potnis, Jessica B Long

|Feb 13, 2024
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.

Scott F Huntington, Enrico de Nigris, Justin T Puckett

|Dec 05, 2023
Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma.

Mahek Garg, Justin Puckett, Sachin Kamal-Bahl

Pageof 5

Frequent Collaborators

8 joint publications

Nikolai A Podoltsev

6 joint publications

Amy J Davidoff

6 joint publications

Rory M Shallis

3 joint publications

Justin T Puckett